Medical Health & Life Science Research News

Report explores the global blood preparation market forecast to 2024

Medical Market Research adds a New Blood Preparation Market Research Report for the period of 2016 - 2024 that shows the growth of the market is rising at 2024.

Blood Preparation Market size is poised to surpass USD 64.38 billion by 2024; according to a new research report.

Technological advancements in testing equipments such as centrifuges and analyzers have enabled rapid and accurate diagnostics of hematological disorders. Early diagnosis of disorders coupled with increasing number of cost-effective therapeutic drugs should accelerate forecast industry growth.

However, acquiring blood transmitted diseases such as HIV, Hepatitis B during transfusion is a major restraint for the industry growth.

Increasing geriatric population and rising prevalence of chronic diseases such as diabetes, glomerulonephritis will increase the patient pool requiring transfusion. Furthermore, favorable government initiatives to spread the awareness regarding blood disorders will drive the business growth.

For instance, NIH and CDC are organizing awareness programs to prevent thrombosis-related complications within the country.

Introduction of novel antithrombotic drugs exhibiting higher efficacy should drive blood preparation market size. Furthermore, presence of strong pipeline of drugs for thrombosis and other blood disorders will propel growth.

Get sample Copy of this report:…?utm_source=WT-SL

Blood Preparation market by product:

  • Ø Whole Blood
  • Ø Red Cells
  • Ø Granulocytes
  • Ø Plasma
  • Ø Platelets

Blood Preparation market by Components:

  • Ø Whole Blood Components
  • Ø Packed Red Cells
  • Ø Leukocyte Reduced Red Blood Cells
  • Ø Frozen Plasma
  • Ø Platelet Concentrate
  • Ø Cryoprecipitate

The above information is provided on a regional and country basis for the following:

  • Ø North America
  • Ø Europe
  • Ø Asia Pacific
  • Ø Latin America
  • Ø MEA

Blood Components:

  • Ø Whole Blood Components
  • Ø Packed Red Cells
  • Ø Leukocyte Reduced Red Blood Cells
  • Ø Frozen Plasma
  • Ø Platelet Concentrate
  • Ø Cryoprecipitate

Blood Derivatives preparation market by Application: Pulmonary Embolism

  • Ø Thrombocytosis
  • Ø Renal Impairment
  • Ø Angina Blood Vessel Complications  

Blood preparation market by Antithrombotic and Anticoagulants (Revenue, USD Million, 2012 - 2024):


  • Ø Platelet Aggregation Inhibitors
  • Ø Glycoprotein Inhibitors
  • Ø COX Inhibitors
  • Ø ADP Antagonists
  • Ø Phosphodiesterase Inhibitors
  • Ø Fibrinolytic
  • Ø Tissue Plasminogen Activator (tPA)
  • Ø Streptokinase
  • Ø Urokinase


  • Ø Heparins
  • Ø Unfractionated Heparin
  • Ø Low Molecular Weight Heparin (LMWH)
  • Ø Ultra-low Molecular Weight Heparin
  • Ø Vitamin K Antagonists
  • Ø Direct Thrombin Inhibitors
  • Ø Direct Factor Xa Inhibitors

Growth drivers:

  • Ø Increasing geriatric population
  • Ø Presence of advanced technology for blood preparation and storage
  • Ø Increasing usage of plasma in pharmaceutical industry
  • Ø Rising demand for whole blood and blood components transfusion
  • Ø Industry pitfalls & challenges
  • Ø Risk of blood transmitted diseases and growing blood substitutes

Whole blood preparation market size was responsible for over 45% global income in 2015 and will reach nearly USD 29.5 billion by 2024. Anticoagulants led the overall antithrombotic and anticoagulants market share with revenue of over 60% in 2015 due to increasing prevalence of blood related diseases and growing demand for cost-effective and efficacious drugs.

U.S. blood preparation market is poised to exceed 25 billion by 2024 owing to initiatives taken by regulatory organizations to spread awareness about the complications associated with pulmonary embolism (PE) and deep vein thrombosis (DVT). FDA regulates collection, storage, preparation, and transport of blood and collaborating with other agencies for implementation of health insurance to achieve adequate reimbursement for blood components.

France and Germany will be frontrunners from Europe, with German revenue to exceed USD 4.2 billion owing to the growing aging population and better healthcare facilities. China holds majority regional revenue share owing to high population with unmet needs, growing geriatric population base, and rise in patient awareness levels.

Moreover, introduction of advanced technological products and rising healthcare expenditures will drive the blood preparation industry share.

Get this Report:…?utm_source=WT-SL

Global Blood Preparation market share for footwear accounted for more than half of the industry volume in 2016. Escalating global footwear sales primarily due to upgrading consumer lifestyle along with increasing customer spending power over the past few years is analyzed to be the major factor propelling business growth.

Leather chemical market size for automotive shall observe growth close to 5% by 2024. The growth in the segment will be particularly due to rising leather demand for interiors (dashboard, seat covers,.) in personal cars.

In 2016, North America Blood Preparation market size was more than USD 1 billion. The regional growth was mainly due to favoring regulations towards PPE use in manufacturing industries.

Furthermore, massive customer base for leather shoes and gloves in the region will complement business growth by 2024.

In 2016, Asia Pacific Blood Preparation market share accounted for a major industry chunk. This massive regional industry size is mainly due to robust leather production in China and India.

For instance, India and China holds over 40% of the global leather export.

Global Blood Preparation market size was competitive in 2016, as the major industry competitors had presence across multiple stages of the industry ecosystem and are involved in strategic mergers & acquisitions in order to achieve competitive edge in the business. Major industry contributors are BASF, Bayer, Clariant, Lanxess, Schill & Seilacher, Lawrence International and Zschimmer & Schwarz.

News From

Market Study ReportMarket Study Report
Category: Market Research Publishers and RetailersCompany about: Centralize market research purchases across your entire organization in one allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management. 
This email address is being protected from spambots. You need JavaScript enabled to view it.